Introduction {#Sec1}
============

Bilirubin toxicity to the CNS has been extensively studied for decades and has been shown to be linked to the activation of multiple complex signal cascades, and affects potential toxic/adaptation mechanisms in the brain through gene expression modulation. Examples include oxidative stress and the antioxidant response, excitotoxicity, inflammation, intracellular trafficking, protein degradation, apoptosis, as well as bilirubin transport and bilirubin oxidization (reviewed in^[@CR1]^).

Epigenetic processes, such as histone acetylation and DNA methylation, regulate the expression of genes through modifications of DNA structure and accessibility. These regulatory mechanisms often contribute to the onset and progression of human neurological disorders, and are altered by toxic compounds (e.g.: cocaine, alcohol)^[@CR2]--[@CR8]^. Indeed, histone acetylation is considered an integral part of brain development and differentiation, synaptic plasticity, learning, memory, and neuron maintenance and survival^[@CR9]--[@CR12]^. Notably, it is reported that temporal changes in gene expression by acetylation/deacetylation of gene promoters induce persistent changes in the cell (e.g. cell fate), changes in the neurological behaviour^[@CR8]^, as well induction of excitotoxicity, calcium overload, oxidative stress, inflammation and apoptosis^[@CR13]^, with the last five described mechanisms in hyperbilirubinemic animals and humans. This suggests the possibility of a link between the hyperbilirubinemic phenotype and the epigenetic. On this basis, we decided to investigate the effect of hyperbilirubinemia on the epigenetic control of the Cll hypoplasia.

Results {#Sec2}
=======

Serum bilirubin and cerebellar development {#Sec3}
------------------------------------------

To evaluate the possible correlation between serum bilirubin and the levels of H3K14Ac, we quantified total and free bilirubin in the blood, and the Cll weight in hyperbilirubinemic pups (jj) and normobilirubinemic littermates (control: ctrl) from 2 days after birth (P2) until the adult age. At every post-natal age, the total serum bilirubin (TSB, Fig. [1A](#Fig1){ref-type="fig"}) was statistically higher in jj animals compared to ctrl (Σ8.5 lifelong, one-way ANOVA: p ≤ 0.0001, followed by Tukey post-test, p ≤ 0.001). At P2, the TSB was about of 190 µM, peaking at P17 (Σ256 µM), and stabilizing in the adulthood (Σ126 µM), (ever significantly higher than in ctrl, one-way ANOVA: p ≤ 0.0001, followed by Tukey post-test, p ≤ 0.001).Figure 1Total Serum Bilirubin (TSB), calculated free bilirubin (cBf) in the blood, cerebellar weight, and Western blot analysis of the level of histone 3 acetylation (H3K14Ac) P: post-natal age in days, Adult: more than 1-year-old. Black bars jj rats, White bars: ctrls. (**A**) TSB (µM); (**B**) cBf (nM), (**C**) Cll weight (mg/animal). Results are expressed as mean ± S.D. of 6--15 animals each group and post-natal age. One way ANOVA followed by Tukey post-test: \*\*\*p \< 0.001. (**D**) H3K14Ac levels in the Cll of jj animals *vs*. ctrl. Results are as mean ± S.D. of 3--6 animals each group and post-natal age. Unpaired t-test with Welch correction, \*p \< 0.05 vs. age matched ctrl.

Free bilirubin is the moiety able to cross the blood-brain interfaces leading to neurological damage. In the absence of a reliable method for a direct quantification in the rat, free bilirubin was calculated as previously described^[@CR14]^. Differently from TSB, the calculated Bf (cBf, Fig. [1B](#Fig1){ref-type="fig"}) level in jj pups dropped during development (P2 Σ150 nM, P9 Σ120 nM, P17 Σ35 nM, ever significantly higher than in ctrl, one-way ANOVA: p ≤ 0.0001, followed by Tukey post-test, p ≤ 0.001~~)~~, felling to the levels not statistically different from those in ctrl in the adult age (adult jj Σ7 nM; One way ANOVA, followed by Tukey post-test, p \> 0.05).

Cll weight (Fig. [1C](#Fig1){ref-type="fig"}) was similar in jj and ctrl littermates up to P9, becoming significantly different at P17 (Σ30% weight loss *vs*. age-matched ctrl, one way ANOVA followed by Tukey post-test: p \< 0.001), and increasing later on (Adult: Σ40%, one way ANOVA followed by Tukey post-test: p \< 0.001).

Western blot analysis of global acetylation of histone H3K14 {#Sec4}
------------------------------------------------------------

The follow the level of H3K14Ac in the developing cerebellum of jj and controls rats by Western blot, we used the 07-353 anti-H3K13Ac antibody. At P2, no significant difference was observed in the level of H3K14Ac in the Cll of jj animals compared to age-matched ctrl (Fig. [1D](#Fig1){ref-type="fig"}) (unpaired t-test with Welch correction, p = 0.2687). The level of H3K14Ac in jj was significantly increased (1.65 ± 0.54 fold, unpaired t-test with Welch correction, p \< 0.0222) at P9 and significantly decreased at P17 (0.67 ± 0.18 fold, unpaired t-test with Welch correction, p \< 0.0187). In the adults there was no difference in the level of H3K14Ac between jj and ctrl (unpaired t-test with Welch correction, p = 0.4508).

ChIP-Seq analysis {#Sec5}
-----------------

To link the effect of hyperbilirubinemia on H3K14Ac with the genes controlled by this epigenetic mechanism, the 07--353 anti-H3K13Ac antibody used for Western blot analysis was also used to perform chromatin immunoprecipitation, followed by DNA sequencing (ChIP-Seq -- full result available on GEO repository \# GSE109145). After removal of duplicate DNA fragments and DNA fragments present in both jj and ctrl (physiological genes), 1884 unique DNA sequences were identified. Since variations in the level of histone acetylation in the promoter region positively correlate with gene transcription^[@CR9],[@CR15]^, we focused on peaks identified by ChIP-Seq on the promoter regions (Table [1](#Tab1){ref-type="table"}: 255 genes). As shown in Fig. [2](#Fig2){ref-type="fig"}, the functional annotation analysis of the corresponding genes^[@CR16]--[@CR18]^ revealed an enrichment for genes involved in CNS development (Σ45%), metabolism & homeostasis (Σ31%), signalling (Σ13%), response to stimuli & communication (Σ5%), transport (Σ5%), and binding (Σ2%).Table 1Full list of ChIP-Seq TSS-Promoter genes.Gene NameGene DescriptionNearest RefseqGene Type*Abcc10*ATP-binding cassette, subfamily C (CFTR/MRP), member 10NM_001108201protein-coding*Acot13*acyl-CoA thioesterase 13NM_001106111protein-coding*Acp1*acid phosphatase 1, solubleNM_021262protein-coding*Acpt*acid phosphatase, testicularNM_001107510protein-coding*Actc1*actin, alpha, cardiac muscle 1NM_019183protein-coding*Adra2b*adrenoceptor alpha 2BNM_138505protein-coding*Agrn*agrinNM_175754protein-coding*Ahrr*aryl-hydrocarbon receptor repressorNM_001024285protein-coding*Aldh3a2*aldehyde dehydrogenase 3 family, member A2NM_031731protein-coding*Alg11*ALG11, alpha-1,2-mannosyltransferaseNM_001108401protein-coding*Alg8*ALG8, alpha-1,3-glucosyltransferaseNM_001034127protein-coding*Amdhd1*amidohydrolase domain containing 1NM_001191781protein-coding*Anxa2*annexin A2NM_019905protein-coding*Arfgap2*ADP-ribosylation factor GTPase activating protein 2NM_001033707protein-coding*Arhgap4*Rho GTPase activating protein 4NM_144740protein-coding*Asl*argininosuccinate lyaseNM_021577protein-codingAtp6v0e1ATPase, H+ transporting, lysosomal, V0 subunit e1NM_053578protein-codingAtraidall-trans retinoic acid-induced differentiation factorNM_001127526protein-codingB3galt4UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4NM_133553protein-codingBbs2Bardet-Biedl syndrome 2NM_053618protein-codingBbs5Bardet-Biedl syndrome 5NM_001108583protein-codingBin2bridging integrator 2NM_001012223protein-codingBphlbiphenyl hydrolase-like (serine hydrolase)NM_001037206protein-codingBrd9bromodomain containing 9NM_001107453protein-codingCacng8calcium channel, voltage-dependent, gamma subunit 8NM_080696protein-codingCap1CAP, adenylate cyclase-associated protein 1 (yeast)NM_022383protein-codingCasp6caspase 6NM_031775protein-codingCblcCbl proto-oncogene C, E3 ubiquitin protein ligaseNM_001034920protein-codingCct6achaperonin containing Tcp1, subunit 6 A (zeta 1)NM_001033684protein-codingCdc20cell division cycle 20NM_171993protein-codingCers1ceramide synthase 1NM_001044230protein-codingChadchondroadherinNM_019164protein-codingChmp1acharged multivesicular body protein 1 ANM_001083313protein-codingChrnb1cholinergic receptor, nicotinic, beta 1 (muscle)NM_012528protein-codingCiapin1cytokine induced apoptosis inhibitor 1NM_001007689protein-codingCideacell death-inducing DFFA-like effector aNM_001170467protein-codingClpsl2colipase-like 2NM_001135002protein-codingCnksr1connector enhancer of kinase suppressor of Ras 1NM_001039011protein-codingCol4a3collagen, type IV, alpha 3NM_001135759protein-codingCol7a1collagen, type VII, alpha 1NM_001106858protein-codingCpne6copine VI (neuronal)NM_001191113protein-codingCpsf3lcleavage and polyadenylation specific factor 3-likeNM_001033892protein-codingCpsf4cleavage and polyadenylation specific factor 4NM_001012351protein-codingCrcpCGRP receptor componentNM_053670protein-codingCthcystathionine gamma-lyaseNM_017074protein-codingCtr9CTR9 homolog, Paf1/RNA polymerase II complex componentNM_001100661protein-codingCyb5r1cytochrome b5 reductase 1NM_001013126protein-codingCybacytochrome b-245, alpha polypeptideNM_024160protein-codingDdb1damage-specific DNA binding protein 1, 127 kDaNM_171995protein-codingDdb2damage specific DNA binding protein 2NM_001271346protein-codingDdiasDNA damage-induced apoptosis suppressorNM_001126294protein-codingDdit4l2DNA-damage-inducible transcript 4-like 2NM_080399protein-codingDdx55DEAD (Asp-Glu-Ala-Asp) box polypeptide 55NM_001271326protein-codingDdx56DEAD (Asp-Glu-Ala-Asp) box helicase 56NM_001004211protein-codingDhddsdehydrodolichyl diphosphate synthase subunitNM_001011978protein-codingDmrtc2DMRT-like family C2NM_001109140protein-codingDnaja1DnaJ (Hsp40) homolog, subfamily A, member 1NM_022934protein-codingEif3eeukaryotic translation initiation factor 3, subunit ENM_001011990protein-codingEmc3ER membrane protein complex subunit 3NM_001008355protein-codingEmdemerinNM_012948protein-codingEntpd6ectonucleoside triphosphate diphosphohydrolase 6NM_053498protein-codingEny2enhancer of yellow 2 homolog (Drosophila)NM_001130580protein-codingEphx2epoxide hydrolase 2, cytoplasmicNM_022936protein-codingFam151afamily with sequence similarity 151, member ANM_001005558protein-codingFam178bfamily with sequence similarity 178, member BNM_001122653protein-codingFam192afamily with sequence similarity 192, member ANM_001014014protein-codingFancaFanconi anemia, complementation group ANM_001108455protein-codingFbxo44F-box protein 44NM_001191576protein-codingFdxrferredoxin reductaseNM_024153protein-codingFgfr1op2FGFR1 oncogene partner 2NM_201421protein-codingFkbp6FK506 binding protein 6NM_001105922protein-codingFoxm1forkhead box M1NM_031633protein-codingFyco1FYVE and coiled-coil domain containing 1NM_001106870protein-codingGamtguanidinoacetate N-methyltransferaseNM_012793protein-codingGdf1growth differentiation factor 1NM_001044240protein-codingGja4gap junction protein, alpha 4NM_021654protein-codingGjd4gap junction protein, delta 4NM_001100487protein-codingGna15guanine nucleotide binding protein, alpha 15NM_053542protein-codingGng5guanine nucleotide binding protein (G protein), gamma 5NM_024377protein-codingGnmtglycine N-methyltransferaseNM_017084protein-codingGnpatglyceronephosphate O-acyltransferaseNM_053410protein-codingGosr2golgi SNAP receptor complex member 2NM_031685protein-codingGpalpp1GPALPP motifs containing 1NM_001024875protein-codingGtf2e1general transcription factor IIE, polypeptide 1, alphaNM_001100556protein-codingGtsf1gametocyte specific factor 1NM_001079707protein-codingGzf1GDNF-inducible zinc finger protein 1NM_001107788protein-codingHcfc1r1host cell factor C1 regulator 1 (XPO1-dependent)NM_001100492protein-codingHigd2aHIG1 hypoxia inducible domain family, member 2 ANM_001106102protein-codingHist3h2ahistone cluster 3, H2aNM_021840protein-codingHist3h2bbhistone cluster 3, H2bbNM_001109641protein-codingHoxc8homeobox C8NM_001177326protein-codingHoxd10homeo box D10NM_001107094protein-codingHrghistidine-rich glycoproteinNM_133428protein-codingIcam1intercellular adhesion molecule 1NM_012967protein-codingIduaiduronidase, alpha-L-NM_001172084protein-codingIft122intraflagellar transport 122NM_001009416protein-codingIkzf5IKAROS family zinc finger 5NM_001107555protein-codingIl17rbinterleukin 17 receptor BNM_001107290protein-codingItga4integrin, alpha 4NM_001107737protein-codingJagn1jagunal homolog 1NM_001044272protein-codingJtbjumping translocation breakpointNM_019213protein-codingKb15type II keratin Kb15NM_001008825protein-codingKcne5potassium channel, voltage-gated Isk-related subfamily E regulatory beta subunit 5NM_001101003protein-codingKdelr1KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1NM_001017385protein-codingKiaa0895lhypothetical protein LOC688736NM_001044292protein-codingKif11kinesin family member 11NM_001169112protein-codingKif18bkinesin family member 18BNM_001039019protein-codingKlrd1killer cell lectin-like receptor, subfamily D, member 1NM_012745protein-codingKrt33bkeratin 33BNM_001008819protein-codingLars2leucyl-tRNA synthetase 2, mitochondrialNM_001108787protein-codingLeng1leukocyte receptor cluster (LRC) member 1NM_001106218protein-codingLhx1LIM homeobox 1NM_145880protein-codingLOC100912214uncharacterized LOC100912214NR_131101ncRNALOC103689982lysophospholipid acyltransferase 7NM_001313940protein-codingLOC288913similar to LEYDIG CELL TUMOR 10 KD PROTEINNM_198728protein-codingLOC498154hypothetical protein LOC498154NM_001025033protein-codingLOC688925similar to Glutathione S-transferase alpha-4NM_001270386protein-codingLrrc14leucine rich repeat containing 14NM_001024354protein-codingLrrc27leucine rich repeat containing 27NM_001113789protein-codingLrrc36leucine rich repeat containing 36NM_001004088protein-codingLrrc51leucine rich repeat containing 51NM_001106284protein-codingLypd3Ly6/Plaur domain containing 3NM_021759protein-codingLzicleucine zipper and CTNNBIP1 domain containingNM_001013241protein-codingLztfl1leucine zipper transcription factor-like 1NM_001024266protein-codingMaf1MAF1 homolog, negative regulator of RNA polymerase IIINM_001014085protein-codingMagmyelin-associated glycoproteinNM_017190protein-codingMalmal, T-cell differentiation proteinNM_012798protein-codingMboat7membrane bound O-acyltransferase domain containing 7NM_001134978protein-codingMcemp1mast cell-expressed membrane protein 1NM_001134602protein-codingMea1male-enhanced antigen 1NM_001044286protein-codingMed11mediator complex subunit 11NM_001105799protein-codingMir137microRNA 137NR_031883ncRNAMir207microRNA 207NR_032107ncRNAMir338microRNA 338NR_031783ncRNAMir3562microRNA 3562NR_037344ncRNAMispmitotic spindle positioningNM_001109284protein-codingMrpl43mitochondrial ribosomal protein L43NM_001107598protein-codingMrps18bmitochondrial ribosomal protein S18BNM_212534protein-codingMrps25mitochondrial ribosomal protein S25NM_001025408protein-codingMt2Ametallothionein 2ANM_001137564protein-codingMt3metallothionein 3NM_053968protein-codingMterf3mitochondrial transcription termination factor 3NM_199387protein-codingMtf1metal-regulatory transcription factor 1NM_001108677protein-codingMtf2metal response element binding transcription factor 2NM_001100898protein-codingMyeov2myeloma overexpressed 2NM_001109044protein-codingNaa38N(alpha)-acetyltransferase 38, NatC auxiliary subunitNM_001105794protein-codingNcbp1nuclear cap binding protein subunit 1NM_001014785protein-codingNcoa4nuclear receptor coactivator 4NM_001034007protein-codingNdor1NADPH dependent diflavin oxidoreductase 1NM_001107818protein-codingNdufb8NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8NM_001106360protein-codingNdufs5NADH dehydrogenase (ubiquinone) Fe-S protein 5NM_001030052protein-codingNdufv3NADH dehydrogenase (ubiquinone) flavoprotein 3NM_022607protein-codingNipsnap1nipsnap homolog 1 (C. elegans)NM_001100730protein-codingNme3NME/NM23 nucleoside diphosphate kinase 3NM_053507protein-codingNmiN-myc (and STAT) interactorNM_001034148protein-codingNmuneuromedin UNM_022239protein-codingNob1NIN1/RPN12 binding protein 1 homologNM_199086protein-codingNolc1nucleolar and coiled-body phosphoprotein 1NM_022869protein-codingNr2c2apnuclear receptor 2C2-associated proteinNM_001047104protein-codingNsl1NSL1, MIS12 kinetochore complex componentNM_001109083protein-codingNtpcrnucleoside-triphosphatase, cancer-relatedNM_001134573protein-codingNtsr1neurotensin receptor 1NM_001108967protein-codingNubp2nucleotide binding protein 2NM_001011891protein-codingNudt2nudix (nucleoside diphosphate linked moiety X)-type motif 2NM_207596protein-codingOlr437olfactory receptor 437NM_001109347protein-codingOlr760olfactory receptor 760NM_001001069protein-codingOvca2ovarian tumor suppressor candidate 2NM_001109036protein-codingPcdha3protocadherin alpha 3NM_053941protein-codingPctpphosphatidylcholine transfer proteinNM_017225protein-codingPex1peroxisomal biogenesis factor 1NM_001109220protein-codingPhlda2pleckstrin homology-like domain, family A, member 2NM_001100521protein-codingPhldb3pleckstrin homology-like domain, family B, member 3NM_001191622protein-codingPigpphosphatidylinositol glycan anchor biosynthesis, class PNM_001099758protein-codingPlcxd2phosphatidylinositol-specific phospholipase C, X domain containing 2NM_001134481protein-codingPlp2proteolipid protein 2 (colonic epithelium-enriched)NM_207601protein-codingPmf1polyamine-modulated factor 1NM_001191568protein-codingPnldc1poly(A)-specific ribonuclease (PARN)-like domain containing 1NM_001025724protein-codingPolr3dpolymerase (RNA) III (DNA directed) polypeptide DNM_001031653protein-codingPou6f1POU class 6 homeobox 1NM_001105746protein-codingPpp1r11protein phosphatase 1, regulatory (inhibitor) subunit 11NM_212542protein-codingPpt2palmitoyl-protein thioesterase 2NM_019367protein-codingPsmg4proteasome (prosome, macropain) assembly chaperone 4NM_001109543protein-codingPtcd1pentatricopeptide repeat domain 1NM_001109665protein-codingPtk2bprotein tyrosine kinase 2 betaNM_017318protein-codingQkquakingNM_001115021protein-codingRab3gap2RAB3 GTPase activating protein subunit 2NM_001008294protein-codingRab5cRAB5C, member RAS oncogene familyNM_001105840protein-codingRad51ap1RAD51 associated protein 1NM_001079711protein-codingRanbp10RAN binding protein 10NM_001135875protein-codingRec8REC8 meiotic recombination proteinNM_001011916protein-codingRfc2replication factor C (activator 1) 2NM_053786protein-codingRGD1307443similar to mKIAA0319 proteinNM_001197023protein-codingRGD1309188similar to hypothetical protein BC011833NM_001108129protein-codingRGD1309676similar to RIKEN cDNA 5730469M10NM_001014140protein-codingRGD1311703similar to sid2057pNM_001013898protein-codingRGD1359334similar to hypothetical protein FLJ20519NM_001007638protein-codingRGD1559909RGD1559909NM_001108678protein-codingRGD1560608similar to novel proteinNM_001109280protein-codingRGD1562683RGD1562683NM_001108314protein-codingRGD1563714RGD1563714NM_001126297protein-codingRGD1564036similar to RIKEN cDNA 3010026O09NM_001109030protein-codingRibc2RIB43 A domain with coiled-coils 2NM_001013949protein-codingRnf40ring finger protein 40, E3 ubiquitin protein ligaseNM_153471protein-codingRph3arabphilin 3ANM_133518protein-codingRpl27ribosomal protein L27NM_022514protein-codingRpl27aribosomal protein L27aNM_001106290protein-codingRspry1ring finger and SPRY domain containing 1NM_001100945protein-codingRxfp3relaxin/insulin-like family peptide receptor 3NM_001008310protein-codingSart3squamous cell carcinoma antigen recognized by T-cells 3NM_001107156protein-codingSclyselenocysteine lyaseNM_001007755protein-codingSert1Sertoli cell protein 1NR_130708ncRNASfxn3sideroflexin 3NM_022948protein-codingSkap2src kinase associated phosphoprotein 2NM_130413protein-codingSlc19a2solute carrier family 19 (thiamine transporter), member 2NM_001030024protein-codingSlc25a54solute carrier family 25, member 54NM_001109640protein-codingSlc43a3solute carrier family 43, member 3NM_001107743protein-codingSlc5a6solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6NM_130746protein-codingSlc6a20solute carrier family 6 (proline IMINO transporter), member 20NM_133296protein-codingSlc6a3solute carrier family 6 (neurotransmitter transporter), member 3NM_012694protein-codingSnrnp35small nuclear ribonucleoprotein 35 (U11/U12)NM_001014127protein-codingSnrpb2small nuclear ribonucleoprotein polypeptide B"NM_001108592protein-codingSpag7sperm associated antigen 7NM_001107016protein-codingSpata33spermatogenesis associated 33NM_001106195protein-codingSpata5spermatogenesis associated 5NM_001108549protein-codingSpicSpi-C transcription factor (Spi-1/PU.1 related)NM_001108080protein-codingStamsignal transducing adaptor molecule (SH3 domain and ITAM motif) 1NM_001109121protein-codingStk19serine/threonine kinase 19NM_001013197protein-codingSusd3sushi domain containing 3NM_001107341protein-codingTada3transcriptional adaptor 3NM_001025734protein-codingTaf6lTAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factorNM_001107575protein-codingTax1bp3Tax1 (human T-cell leukemia virus type I) binding protein 3NM_001025419protein-codingTbc1d25TBC1 domain family, member 25NM_001106955protein-codingTbcbtubulin folding cofactor BNM_001040180protein-codingThem4thioesterase superfamily member 4NM_001025017protein-codingTmem109transmembrane protein 109NM_001007736protein-codingTmem126atransmembrane protein 126 ANM_001011557protein-codingTnxa-ps1tenascin XA, pseudogene 1NR_024118pseudoTrappc1trafficking protein particle complex 1NM_001039378protein-codingTrim23tripartite motif-containing 23NM_001100637protein-codingTrip13thyroid hormone receptor interactor 13NM_001011930protein-codingTrip4thyroid hormone receptor interactor 4NM_001134981protein-codingTrmt112tRNA methyltransferase 11-2 homolog (S. cerevisiae)NM_001106330protein-codingTsc2tuberous sclerosis 2NM_012680protein-codingTstd2thiosulfate sulfurtransferase (rhodanese)-like domain containing 2NM_001108663protein-codingTtc3tetratricopeptide repeat domain 3NM_001108315protein-codingTuba3atubulin, alpha 3ANM_001040008protein-codingTuba4atubulin, alpha 4ANM_001007004protein-codingTubb2btubulin, beta 2B class IIbNM_001013886protein-codingUfsp2UFM1-specific peptidase 2NM_001014142protein-codingVmp1vacuole membrane protein 1NM_138839protein-codingVwa7von Willebrand factor A domain containing 7NM_212499protein-codingZbtb26zinc finger and BTB domain containing 26NM_001107840protein-codingZfp142zinc finger protein 142NM_001108225protein-codingZfp597zinc finger protein 597NM_153732protein-codingZscan21zinc finger and SCAN domain containing 21NM_001012021protein-codingFigure 2Biological function of the identified Chip-Seq chromatin sequences (**A**) GeneCodis analysis (on genes with peaks found in their TSS-promoter regions) for enriched biological functions. (**B**) List of the 94 (45% of the total found) genes enriched for functions related to the CNS development. In red, genes confirmed by RTqPCR. Hypergeometric p-value ever \<0.00005, Corrected (FDR) Hypergeometric p-value \< 0.05.

Morphological features of the Gunn rat Cll {#Sec6}
------------------------------------------

Since our results strongly suggested an impact of bilirubin on the genetic program of CNS maturation, we systematically followed the histological development of the cerebellum of jj rats in the attempt to interpret the genetic results. No morphological alterations between jj and ctrl were obvious at P2 (Fig. [3A,B](#Fig3){ref-type="fig"}). In both jj and ctrl animals, Purkinje cells were organized in 3--5 layers, with a round/oval shape and a reticulated cytoplasm (Fig. [3B](#Fig3){ref-type="fig"}). At P9, in spite of a conserved architecture, signs of cellular sufferance/death, microgliosis, extracellular matrix abnormalities and edema were evident in jj pups. PCs in ctrl displayed a clear definition of the plasma-membrane, cytoplasm, and nuclear areas, and a round/drop shape, and were organized in 3/1 layers. On the contrary, in jj pups, PCs were largely present in 4/2 layers, with an undefined, irregular shape. At P17, microgliosis and signs of cellular sufferance were still present in jj rats. PCs in ctrl were well differentiated, with a drop shape, and almost completely organized in a single layer, diffusely in 2/1 layers and still presenting the altered morphology described at P9 in jj. In the adult animal, the effect of Cll hypoplasia was well appreciable, with a less developed structure characterized by large spaces between the folia (Fig. [3A](#Fig3){ref-type="fig"}). Microgliosis was reduced but still present. No PC's neurites were visible in jj rats, where PCs appeared atrophic and apoptotic (Fig. [3B](#Fig3){ref-type="fig"}).Figure 3Histological finding (**A**) Full Cll images (scale bar 400 µm) showing the normal development (ctrl, upper series of pictures) and the progression of the Cll hypoplasia in jj animals (lower series of pictures). (**B**) Details (scale bar 100 µm) of the major histological alterations in the developing Cll of jj rat *vs*. age matched ctrl. P: post-natal age in days, Adult: more than 1 year old. \*Purkinje cells (PCs); \>PC's neurites; ∆ microgliosis; \[\] extracellular matrix alteration; → oedema. 2--3 animals each genotype/age have been used. Miniatures: Nissl stain. Larger pictures: Haematoxylin & Eosin.

RTqPCR analysis of selected genes {#Sec7}
---------------------------------

Due to the surprising percentage of enrichment for genes involved in CNS development, we decided to confirm and quantify the epigenetic control of a selected panel of genes, by assessing their expression by RTqPCR (selected genes are those in red in Fig. [2B](#Fig2){ref-type="fig"}, in which their biological functions based on the Gene Ontology analysis are indicated. RTqPCR results are in Fig. [4](#Fig4){ref-type="fig"}). *Ptk2* (protein tyrosine kinase 2 beta, considered a key gene in neurite outgrowth and elongation, synapses formation, and actin reorganization^[@CR19]^), was significantly down-regulated in P2 jj pups (Σ2 fold *vs*. age-matched ctrl, unpaired t-test with Welch correction, p \< 0.047), normalizing thereafter. *Mag* (myelin-associated glycoprotein), barely detectable immediately after birth, was highly expressed in ctrl and Σ2.5 fold down-regulated in jj pups at P9 (unpaired t-test with Welch correction, p \< 0.0402), reversing to a Σ1.2 fold up-regulation at P17 (unpaired t-test with Welch correction, p \< 0.0306). *Icam1* (intracellular adhesion molecule 1, expressed mainly by the endothelial cells forming the blood-brain barrier, involved in cell adhesion, leucocytes^[@CR20]^ and monocytes extravasation^[@CR21]^, and morphogenesis) was up-regulated 1.6 fold in P17 jj rats (unpaired t-test with Welch correction, p \< 0.0416). Similarly, we observed a Σ2.2 fold increase (unpaired t-test with Welch correction, p \< 0.0315) of *Chmp1a* (charged multi-vesicular body protein 1a, regulating the neural progenitor cell proliferation^[@CR22]^). In adult jj Cll, *Col4a3* (collagenase 4a3, the major structural component of the basal membrane, involved in the extracellular matrix remodeling^[@CR23]^, providing the functional compartmentalization of the brain by clustering of growth factors, neurotransmitters/ions receptors, as well contributing to migration and differentiation^[@CR24]^), *Casp6* (caspase 6 - proliferation and morphogenesis -- Fig. [2B](#Fig2){ref-type="fig"}), and *Arghap4* (Rho GTPase-activating protein, inhibiting the cell motility and axon outgrowth *via* regulating the cytoskeleton dynamics^[@CR25]^) were upregulated Σ2.5fold (unpaired t-test with Welch correction, p \< 0.00547), Σ1.9fold (unpaired t-test with Welch correction, p \< 0.0287) and Σ1.6 fold (unpaired t-test with Welch correction, p \< 0.0142) respectively. No modulation of *Anxa2* (annexin2), *Agrn* (Agrin), and *Tubb2b* (Tubulin2b) was detected at any post-natal age in jj rats (data not shown). *Il6* (intron region segment resulting from ChIP-Seq analysis) was also investigated. In ctrl animals the *Il6* level rapidly decreases from P2 to P9, stabilizing thereafter. In jj pups, a significant down-regulation of *Il6* was present immediately after birth compared to ctrl animals (Σ2.9fold, unpaired t-test with Welch correction, p \< 0.0315), while a 1.65 fold up-regulation was noticed at P9 (unpaired t-test with Welch correction, p \< 0.0248), normalizing later on.Figure 4Analysis of the expression of selected genes involved in CNS development *Arghap4*: Rho GTP-ase activating protein 4; *Casp6*: Caspase 6; *Chmp1a*: Charged multi-vesicular body protein 1a; *Col4a3*: Collagenase 4 a3; *Icam1*: Intracellular adhesion molecule 1; *Mag*: Myelin-associated glycoprotein; *Ptk2*: Protein tyrosine kinase 2 beta; *Il6*: Interleukin 6. P: post-natal age in days, Adult: more than 1-year-old. White bars: ctrl; Black bars: jj. Results are expressed as mean ± S.D. of 6 animals each genotype/age. Unpaired t-test with Welch correction, \*p \< 0.05; \*\*p \< 0.05; \*\*\*p \< 0.005 vs. age-matched controls.

Discussion {#Sec8}
==========

Cll hypoplasia is a hallmark of hyperbilirubinemia in rodents^[@CR26]--[@CR29]^, and cerebellar involvement with morphological and behavioral abnormalities has also been reported in severely hyperbilirubinemic neonates^[@CR30]--[@CR32]^. Inflammation and oxidative stress are considered the major mechanisms of bilirubin neurotoxicity, whereas the impact of hyperbilirubinaemia on CNS development has been only marginally envisaged, and evaluated mostly by *in vitro* experiments^[@CR33],[@CR34]^.

Unexpectedly, the known inflammatory or oxidant effectors of bilirubin neurotoxicity have been not identified in our data (ChIP-Seq, followed by Gene Ontology analysis), revealing that 45% of genes displaying a Histone 3 lysine 14 acetylation are related to CNS development. Indeed, only 3 genes among all the 255 identified TSS- Promoter sequences have been previously reported in the literature for their association with hyperbilirubinemia, namely *myelin*^[@CR28],[@CR31],[@CR32],[@CR34]^, *tubulin*^[@CR35]^, and *Icam1*^[@CR36]^.

The down-regulation of *Mag* has been reported in *in vitro* studies, in agreement with the defective myelination observed both in bilirubin neurotoxicity models^[@CR28],[@CR34]^ and neonates^[@CR32]^. *Mag* down-regulation is also a known consequence of bilirubin-induced perturbation of the oligodendrocytes maturation. A possible additional link between what has been previously described and the present results is the fact that histone acetylation is a known mechanism controlling oligodendrocyte differentiation and myelin production, both in physiological CNS development and in repair processes after demyelination^[@CR6],[@CR10]^.

Our data are in agreement with the literature also in relation to *Il6*, whose intron sequence was identified by ChIP-Seq analysis. Il6 is a well-known effector of bilirubin neurotoxicity and possibly linked with the reported defective myelination. In fact, apart from the possible inflammatory activity, *Il6* is involved in oligodendrogenesis^[@CR37],[@CR38]^, a process active up to P45 in rodents and 2 years in humans^[@CR39]^, and reactivated in pathological conditions. During reactivation, injured neurons and oligodendrocytes may reactivate myelin synthesis by overexpressing *Il6* and its receptor (*Il6r/CD126*), restoring normal behavior in injured animals^[@CR10],[@CR40]^.

Both *Mag* and *Il6* present a fluctuating behavior, being significantly down-regulated in the early post-natal life, and reverting thereafter to the level of age-matched controls (Fig. [4](#Fig4){ref-type="fig"}). Notably, in our work, *IL6* modulation (P9) precedes *Mag* increase (P17), supporting the inductor role of Il6 in myelination described in the literature^[@CR10],[@CR40]^. The fluctuating expression of *Il6* and *Mag* (firstly up-, then down regulated), is present also for H3K14Ac levels, increasing at P9, and reverting under the level of age-matched controls at P17, and normalizing in the adult age.

The regulation of the other genes is more difficult to be analyzed since they are very new in the bilirubin field and no data are provided by literature. While we still have to confirm the role of the various genes identified in this study through methods such as gene silencing *in vitro*, our work suggests that the epigenetic impairment of neurodevelopmental processes in hyperbilirubinemia may be a relevant mechanism of bilirubin neurotoxicity. It is worth mentioning that *Chmp1a, Arghap4*, *Casp6, Ptk2, Col4a3* are genes involved in key steps of brain development as proliferation, migration, morphogenesis, neurite outgrowth and elongation, synaptogenesis, extracellular matrix formation and compartmentalization, as well the pathological axonal degeneration and apoptosis observed^[@CR19],[@CR22],[@CR25],[@CR41],[@CR42]^ in jj rats. By adding epigenetic dysregulation to the list of the mechanisms related to bilirubin-induced neuronal damage, we can confirm and expand the concept of a widespread toxic effect of the pigment on the CNS^[@CR43]^, improving our understanding of the cellular and molecular mechanisms of bilirubin induced damage to CNS.

Materials and Methods {#Sec9}
=====================

Animals {#Sec10}
-------

Gunn rats (Hds Blue:Gunn-UDPGT^j^, P2, 9, 17; P ± 1 day. Adult = more than 1 year old) were obtained from the SPF animal facility of CBM S.c.a.r.l. (AREA Science Park, Basovizza). Ages were selected based on previous evidence^[@CR26],[@CR44]^. Animals were housed in a temperature-controlled environment (22 ± 2 °C), on a 12 hours light/dark schedule, and ad-libitum access to food and water. The study was approved by the animal care and use committee of the CBM Scarl and the competent Italian Ministry. All procedures were performed according to the Italian Law (decree 87-848) and European Community directive (86-606-ECC). Maximal effort to minimize the number of the animals used and their sufferance was done.

TSB, cBf and Cerebellum weight quantification {#Sec11}
---------------------------------------------

Serum and Cll were collected as previously described^[@CR26],[@CR45]^. In brief, blood samples were collected during the sacrifice (decapitation under urethane anaesthesia 1.0--1.2 g/kg IP) and centrifuged at 2000 rpm, 20 min RT. Total serum bilirubin (TSB) was quantified by the diazo reaction, as previously described^[@CR26]^. Free bilirubin was calculated (cBf) by applying the formula and the albumin-bilirubin dissociation constants for Gunn pups detailed in literature^[@CR14]^. Cerebellum was dissected immediately after the sacrifice, and the weight recorded by a precision balance.

Western blot analysis of the levels of H3K14Ac {#Sec12}
----------------------------------------------

Western blot was performed as previously described^[@CR44],[@CR45]^. In brief, Cll were mechanically homogenized by glass-glass Dounce (in 0.25 M sucrose, 40.2 mM KH~2~PO~4~, 9.8 mM K~2~HPO~4~, 1 mM EDTA, 0.1 mM DTT, pH 7.4), and total protein concentration quantified by the Bicinchoninic Acid Protein Assay following the supplier instruction (B-9643 and C2284, Sigma, Missouri, USA). 25 μg of Cll whole extract proteins were denatured (10% of β-mercaptoethanol -Sigma Chemical, St. Louis, MO, USA, plus 5 min boiling), separated by 12% SDS-PAGE by electrophoresis in a Hoefer SE 250 System (Amersham BioSciences, UK), and electro-transferred onto immune-blot PVDF membranes (0.2 μm; Whatman Schkleicher and Schuell, Dassel, Germany) at 100 V for 60 min (Bio-Rad Laboratories, Hercules, CA, USA). Efficiency of the transfer was assessed by lack of Coomassie blue coloration of the gel after blotting, and Ponceau staining of the PVDF membrane (both chemicals: Sigma, St. Louis, MO, USA). After blocking (1.5 hrs, RT in blocking solution: 3% defatted milk in 0.2% Tween 20; 20 mM Tris-HCl pH 7.5; 500 mM NaCl), membranes were incubated O/N at 4 °C with the polyclonal anti-acetyl histone H3 (lys14) antibody (07-353, Merck Millipore, Temecula, CA, USA; final concentration 0.7 μg/mL). The day after, membranes were washed 3 × 5 min in blocking buffer, then incubated 2hrs with the secondary antibody anti-rabbit IgG peroxidase (Dako, Agilent Technologies, Santa Clara, CA, USA, final concentration 0.0625 μg/mL) in blocking solution. The signal was revealed by chemiluminescence (ECL-Plus Western blotting Detection Reagents, GE-Healthcare Bio-Science, Italy) and visualized on X-ray films (BioMax Light, Kodak Rochester, NY, USA). The results were normalized *vs*. the actin signal, visualized incubating the same membrane used for revealing the H3K14Ac with the anti-actin antibody A2066 (sigma- Chemical, St. Louis, MO, USA; final concentration 0.07 μg/mL, MW 42KDa). Bands intensity was quantified by the Scion Image software (GE Healthcare Europe GmbH, France).

ChIP-Seq analysis {#Sec13}
-----------------

The 07-353 anti-H3K13Ac antibody used for Western blot analysis was also used to perform chromatin immunoprecipitation, followed by DNA sequencing (ChIP-Seq -- full result available on GEO repository \# GSE109145). Chromatin immunoprecipitation (ChIP) was performed following the Magna ChIPTM G Tissue Kit (\#17-20000, Merck Millipore, Temecula, CA, USA) procedure and applying the same Ab used in Western blot. Cll tissue (60 mg) was homogenized, DNA sheared (average size of 100--400 bp, by Sonopuls HD 3100, Bandelin, Germany, sonicator. Power 50%, 15″ × 18 cycles, 10″ pause between each cycle, on ice), cross-linked with 1% formaldehyde (5′, RT), and protein-DNA complexes immune-precipitated (5 μL, 07-353 Ab, Merck Millipore, Temecula, CA, USA) by G magnetic beads on the magnetic rack (LSKMAGS08 Pure ProteomeTM Magnetic Stand, Merck Millipore, Temecula, CA, USA). Protein-DNA crosslink was reversed (proteinase K, 62 °C, 2 h; plus 95° C × 10′), and DNA stored at −20 °C until use. As suggested by the manufacturer, the efficiency and specificity of the ChIP procedure were assessed by Western blot, and Real Time PCR (RTqPCR). Samples were quantified by Quant-iTTM PicoGreen® dsDNA Kits (Thermo Fisher Scientific, Waltham, MA, USA), according to manufacturer's instruction.

Libraries were prepared by using the NEBNext® UltraTM II DNA Library Prep Kit from Illumina® (E7645, New England BioLabs®Inc, MA, USA), following the manufacturer's instructions starting from 10 ng of fragmented DNA. After end repair and adaptor ligation, adaptor-ligated DNA clean-up (without size-selection, Agencourt AMPure XP magnetic beads, Beckman Coulter Life Sciences, CA, USA), library enrichment (98°C × 30 sec; 98°C × 10 secplus 65°C × 75 min × 10 cycles; 65°C × 5 min, in a Bio-Rad thermal cycler, Bio-Rad, Richmond, CA, USA), and PCR clean up (Agencourt AMPure XP magnetic beads, Beckman Coulter Life Sciences, CA, USA), the libraries were quantified using the PicoGreen fluorescent dye, as reported above, and stored at −20 °C. Before sequencing, libraries were denatured and diluted to a final concentration of 15 pM with 10% PhiX (Illumina, New England BioLabs®Inc, MA, USA) control. Paired-end sequencing was performed using the MiSeq reagent kit v3 2 × 150 in the Illumina® MiSeq® system (Illumina, San Diego, CA, USA). A total of 4 P9 jj Cll (2 runs) and 3 P9 control Cll (1 run) were used. Reads were mapped to the Rattus norvegicus (rn4) genome using bowtie2^[@CR46]^. Duplicate reads were filtered. The quality of the sequences was evaluated using fastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). Peaks were called using MACS2^[@CR47]^ and annotated using HOMER software^[@CR48]^. Functional enrichment study was determined using GeneCodis (<http://genecodis.cnb.csic.es/>, hypergeometric test, FDR corrected)^[@CR16]--[@CR18]^.

Histology and morphometric analysis {#Sec14}
-----------------------------------

Immediately after animals sacrifice, the brain was removed from the skull and fixed in 4% formalin buffered solution (4% formaldehyde 37%, 33 nM NaH~2~PO~4~, 46 mM Na~2~HPO~4~), then embedded in paraffin. Sagittal sections of the brain (3--5 μm) were obtained by a microtome (Microm-hm 340 e- BioOptica, Milan, Italy), affixed on the glass slides and dried at 60 °C for 1 hour. Hematoxylin and eosin stain (H&E) was performed by a Leica ST5020 Multistainer (Leica Microsystem, Milan, Italy). Cresyl violet (Nissl) staining was performed manually on hydrated sections (xylol 3 × 5 min; 100% ethanol 2 × 2 min; 95% ethanol 2 × 2 min; 80% ethanol 1 × 2 min; 70% ethanol 1 × 2 min; H~2~O 2 × 5 min) by incubating the slices for 1 hr in cresyl violet solution (0.1% cresyl violet powder, 10 drops glacial acetic acid in H~2~OmQ). After washing (twice H~2~OmQ), differentiation (75% ethanol, 95% ethanol plus 5% chloroform, 3 drops glacial acetic acid) and dehydration (100% ethanol 2 × 5 min; xylol 2 × 5 min), slices were mounted (Eukitt 03989, SIGMA Aldrich). Pictures were collected by a D-Sight plus image digital microscope & scanner (Menarini Diagnostics, Firenze, Italy). Histology was read by 3 independent pathologists, blinded to experimental design.

RTqPCR on selected genes {#Sec15}
------------------------

RTqPCR was performed as previously described^[@CR26],[@CR43]^. Total RNA extraction (Eurogold RNA Pure reagent, Euroclone, Milan, Italy) and retro-transcription (1 μg RNA, High Capacity cDNA Reverse Transcription Kit, Applied Biosystems, Monza, Italy) were performed following the manufacturer instruction in a thermal cycler (Gene Amp PCR System 2400, Perkin-Elmer, Boston, MA, USA) at 25 °C for 5 min, 37 °C for 120 min, and 85 °C for 5 min. The final cDNA was stored at 20 °C until use. Primers were designed using the Beacon designer 8.1 software (Premier Biosoft International, Palo Alto, CA, USA) on rat sequences available in GenBank (Table [2](#Tab2){ref-type="table"}). RtqPCR was performed in an iCycler iQ thermocycler (Bio-Rad Laboratories, Hercules, CA, USA) in presence of 25 ng of cDNA, sense and antisense gene-specific primers (250 nM each), in SSoAdvance SYBER green supermix (Bio-Rad Laboratories, Hercules, CA, USA). Amplification protocol was 95 °C × 3 min, 40 cycle of 95° C × 20 sec; 60 °C × 20 sec and 72 °C × 30 sec, followed by 72 °C × 5 min. Melting curve analysis was performed to assess product specificity. The relative quantification was made using the iCycler iQ Software, version 3.1 (Bio-Rad Laboratories, Hercules, CA, USA) by the Pfaffl modification of the ΔΔCT equation, taking into account the efficiencies of the individual genes^[@CR49],[@CR50]^. The results were normalized to the housekeeping genes and the levels of mRNA were expressed relative to a reference sample^[@CR50],[@CR51]^.Table 2Primers specification.GeneAccession numberForwardReversEfficiencyAmplicon length (bp)*Agrn*NM_175754TACCTGTCCACTTGTATTTTCTCATCCAATAACACATT98.587*Arhgap4*NM_144740CTTGTGAGCCATCTACTATCGTTGAGGAAGGTGAAGAG8875*Anxa2*NM_019905CTACTGTCCACGAAATCCTGAAGTTGGTGTAGGGTTTGAC99.894*Casp6*NM_031775ACAGATGGCTTCTACAGAAGTTCCTCTCCTCTTGTG102.278*Chmp1a*NM_001083313ATCAACTTACAGGTTAGGTACTTACGACAACATTCTA98.2122*Col4a3*NM_001135759TCACCACAATGCCATTCTTACGACAGCCAGTATGAATAGT94.583*Icam1*NM_012967ACCTACATACATTCCTACCATGAGACTCCATTGTTGA96.391*Mag*NM_017190ACCATCCAACCTTCTGTATCCTGATTCCGCTCCAAGTG96.290*Ptk2b*NM_017318TGTCTACACGAACCATAAGAACTTCTCCTTGTTGTC93.188*Tubb2b*NM_001013886CAGTTGGAAGAAGGAGAAAGTGTTACATTGATGTTATCG107.5111*Il6*NM_012589.1GCCCACCAGGAACGAAAGTCTCCTCTGTGAAGTCTCCTCTCC107.7161*Hprt*NM_012583.2AGACTGAAGAGCTACTGTAATGACGGCTGTACTGCTTGACCAAG94.9163

Statistics {#Sec16}
----------

The statistical analysis was performed by GraphPad InStat for Windows (GraphPad Software, Inc, La Jolla, CA, USA). The ANOVA test, followed by Tukey-Kramer multiple comparison tests, was used to analise TSB, cBf, and Cll weight during the development. The unpaired two-tailed Student's t-test, based on unequal variance, was applied to evaluate the difference between jj and controls at the same age (Western blot, RTqPCR). All data are expressed as mean ± S.D. of multiple biological repetition. A p-value lower than 0.05 was considered statistically significant.
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